Literature DB >> 32843412

Subtle case of dapsone-induced methaemoglobinaemia.

Justin S Lewis1, Zachary G Jacobs2.   

Abstract

Methaemoglobinaemia is a rare disease that is typically caused by a medication or other exogenous agent, with dapsone being the most common. It occurs when the concentration of methaemoglobin rises via ferrous haeme irons becoming oxidised to the ferric state, which shifts the oxygen dissociation curve to the left. The net result of an elevated methaemoglobin concentration is functional anaemia and impaired oxygen delivery to tissues. At lower blood levels, this can cause symptoms such as cyanosis, lethargy, headache and fatigue, whereas at higher levels it can be fatal. Here we discuss a subtle case of dapsone-induced methaemoglobinaemia presenting as subacute mental status changes and apparent hypoxia, thus highlighting the association between methaemoglobinaemia and dapsone. This case demonstrates the importance of thorough medication reconciliation and maintaining a broad differential diagnosis, while also recognising the significance of conflicting data and their implications for the workup. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  contraindications and precautions; general practice / family medicine; haematology (drugs and medicines); haematology (incl blood transfusion); rheumatology

Mesh:

Substances:

Year:  2020        PMID: 32843412      PMCID: PMC7449304          DOI: 10.1136/bcr-2020-235403

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.

Authors:  M J Vasconcelles; M V Bernardo; C King; E A Weller; J H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

Review 2.  Methemoglobinemia: a review and recommendations for management.

Authors:  Jessica A Cortazzo; Adam D Lichtman
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-08-13       Impact factor: 2.628

3.  Methemoglobinemia and dapsone levels in patients with leprosy.

Authors:  Jose Luiz Fernandes Vieira; Juan Gonzalo Bardarez Riveira; Ana de Nazaré Silva Martins; Jorge Pereira da Silva; Claudio Guedes Salgado
Journal:  Braz J Infect Dis       Date:  2010 May-Jun       Impact factor: 1.949

Review 4.  Dapsone-induced methemoglobinemia: a primer for clinicians.

Authors:  James A Barclay; Stamatina E Ziemba; Rami B Ibrahim
Journal:  Ann Pharmacother       Date:  2011-08-18       Impact factor: 3.154

Review 5.  Methemoglobinemia: pathogenesis, diagnosis, and management.

Authors:  Anna Skold; Dominique L Cosco; Robin Klein
Journal:  South Med J       Date:  2011-11       Impact factor: 0.954

6.  Dapsone-induced methemoglobinemia: a dose-related occurrence?

Authors:  Adam J Esbenshade; Richard H Ho; Ayumi Shintani; Zhiguo Zhao; Lesley-Ann Smith; Debra L Friedman
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

7.  Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.

Authors:  John V Ashurst; Megan N Wasson; William Hauger; William T Fritz
Journal:  J Am Osteopath Assoc       Date:  2010-01

8.  Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.

Authors:  Rachel Ash-Bernal; Robert Wise; Scott M Wright
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

9.  A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

Authors:  S A Bozzette; D M Finkelstein; S A Spector; P Frame; W G Powderly; W He; L Phillips; D Craven; C van der Horst; J Feinberg
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

  9 in total
  1 in total

1.  Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation.

Authors:  Richard E Kast
Journal:  Med Sci (Basel)       Date:  2021-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.